Teen Pregnancy Linked to Risk of Earlier Death in Adulthood, Study Finds

Teen pregnancy increases the chances that a young woman will drop out of school and struggle with poverty, research has shown. Teenagers are also more likely to develop serious medical complications during pregnancy. Now a large study in Canada reports another disturbing finding: Women who were pregnant as teenagers are more likely to die before… Continue reading Teen Pregnancy Linked to Risk of Earlier Death in Adulthood, Study Finds

FDA Issues Warning of Cancer Risk Tied to CAR-T Therapies

The Food and Drug Administration is requiring companies that make specialized cancer therapies known as CAR-T to add a boxed warning that the treatments themselves may cause cancers. The agency noted that the benefits still outweighed the risks of the therapy, which involves removing a type of white blood cells — T cells — and… Continue reading FDA Issues Warning of Cancer Risk Tied to CAR-T Therapies

Women With Depression During or After Pregnancy Face Greater Suicide Risk, Even Years Later

What the research shows A research team analyzed records of nearly a million women in Sweden’s national medical registries from 2001 through 2017, comparing 86,551 women who had perinatal depression with 865,510 women who did not. The groups were matched by age and year they gave birth. In two studies, the team found that depression… Continue reading Women With Depression During or After Pregnancy Face Greater Suicide Risk, Even Years Later

Ozempic and Wegovy Users Had Less Risk of Suicidal Thoughts in Large Study

People taking the wildly popular drugs Ozempic, to treat diabetes, and Wegovy, to combat obesity, are slightly less likely to have suicidal thoughts who are not taking them, researchers reported on Friday. Millions of people take Ozempic and Wegovy, which are considered to be among the biggest blockbusters in medical history. But last year a… Continue reading Ozempic and Wegovy Users Had Less Risk of Suicidal Thoughts in Large Study

Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.

As Covid rises again, killing about 1,500 Americans each week, medical researchers are trying to understand why so few people are taking Paxlovid, a medicine that is stunningly effective in preventing severe illness and death from the disease. A study of a million high-risk people with Covid found that only about 15 percent who were… Continue reading Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.

Women May Face Higher Risk of Stroke Following Infertility Treatment

Why It Matters: The United States has the highest maternal mortality rate in the developed world. Strokes account for about 7.5 percent of pregnancy-related deaths. At the same time, use of assisted reproductive technology has risen dramatically over the past 10 years. About 2 percent of births in the United States involve infertility treatment of… Continue reading Women May Face Higher Risk of Stroke Following Infertility Treatment

Weight-loss drugs may raise risk of complications under anesthesia

Patients who take blockbuster drugs like Wegovy or Ozempic for weight loss may face life-threatening complications if they need surgery or other procedures that require empty stomachs for anesthesia. This summer’s guidance to halt the medication for up to a week may not go far enough, either. Some anesthesiologists in the U.S. and Canada say… Continue reading Weight-loss drugs may raise risk of complications under anesthesia

Reducing teen’s risk of diabetes

DEAR MAYO CLINIC: I am a 40-year-old overweight woman diagnosed with Type 2 diabetes a little over a year ago. I have become more mindful about the food our family eats, limiting sugar and incorporating more fruits and vegetables into meals at home. Recently, though, I learned my 14-year-old daughter has been “snacking” on spoons… Continue reading Reducing teen’s risk of diabetes

Wegovy Cuts Risk of Heart Problems, Novo Nordisk Trial Says

A new obesity drug, Wegovy, slashed the risk of serious heart problems by 20 percent in a large trial, the drug’s maker said on Tuesday, a finding that could put pressure on insurers to cover the in-demand treatment. The trial — the first to demonstrate that one of the new class of obesity drugs could… Continue reading Wegovy Cuts Risk of Heart Problems, Novo Nordisk Trial Says